Electromed (ELMD) Competitors $20.78 +0.46 (+2.26%) As of 07/3/2025 03:30 PM Eastern Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock ELMD vs. CBLL, BBNX, AVNS, EMBC, BVS, RXST, KIDS, AXGN, BFLY, and DCTHShould you be buying Electromed stock or one of its competitors? The main competitors of Electromed include CeriBell (CBLL), Beta Bionics (BBNX), Avanos Medical (AVNS), Embecta (EMBC), Bioventus (BVS), RxSight (RXST), OrthoPediatrics (KIDS), AxoGen (AXGN), Butterfly Network (BFLY), and Delcath Systems (DCTH). These companies are all part of the "medical equipment" industry. Electromed vs. Its Competitors CeriBell Beta Bionics Avanos Medical Embecta Bioventus RxSight OrthoPediatrics AxoGen Butterfly Network Delcath Systems CeriBell (NASDAQ:CBLL) and Electromed (NYSE:ELMD) are both small-cap medical companies, but which is the superior business? We will contrast the two businesses based on the strength of their media sentiment, valuation, profitability, dividends, analyst recommendations, earnings, institutional ownership and risk. Does the media refer more to CBLL or ELMD? In the previous week, Electromed had 1 more articles in the media than CeriBell. MarketBeat recorded 1 mentions for Electromed and 0 mentions for CeriBell. CeriBell's average media sentiment score of 0.00 equaled Electromed'saverage media sentiment score. Company Overall Sentiment CeriBell Neutral Electromed Neutral Is CBLL or ELMD more profitable? Electromed has a net margin of 11.34% compared to CeriBell's net margin of 0.00%. Electromed's return on equity of 15.71% beat CeriBell's return on equity.Company Net Margins Return on Equity Return on Assets CeriBellN/A N/A N/A Electromed 11.34%15.71%13.37% Do analysts recommend CBLL or ELMD? CeriBell presently has a consensus price target of $32.14, suggesting a potential upside of 69.84%. Electromed has a consensus price target of $38.00, suggesting a potential upside of 82.87%. Given Electromed's stronger consensus rating and higher probable upside, analysts plainly believe Electromed is more favorable than CeriBell.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score CeriBell 0 Sell rating(s) 0 Hold rating(s) 8 Buy rating(s) 0 Strong Buy rating(s) 3.00Electromed 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 1 Strong Buy rating(s) 4.00 Do insiders and institutionals hold more shares of CBLL or ELMD? 40.8% of Electromed shares are owned by institutional investors. 20.1% of CeriBell shares are owned by insiders. Comparatively, 14.0% of Electromed shares are owned by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock is poised for long-term growth. Which has higher valuation and earnings, CBLL or ELMD? Electromed has lower revenue, but higher earnings than CeriBell. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioCeriBell$65.44M10.45-$40.46MN/AN/AElectromed$61.44M2.84$5.15M$0.7926.30 SummaryElectromed beats CeriBell on 9 of the 13 factors compared between the two stocks. Get Electromed News Delivered to You Automatically Sign up to receive the latest news and ratings for ELMD and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding ELMD and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart ELMD vs. The Competition Export to ExcelMetricElectromedElectromedical equipment IndustryMedical SectorNYSE ExchangeMarket Cap$174.26M$32.17M$5.50B$20.64BDividend YieldN/AN/A5.38%3.74%P/E Ratio27.713.5127.5028.09Price / Sales2.84194.58389.6454.25Price / Cash41.3641.3636.6322.31Price / Book4.072.228.074.59Net Income$5.15M-$25.54M$3.17B$986.06M7 Day Performance-5.50%4.26%2.81%2.78%1 Month Performance3.13%111.24%3.69%5.41%1 Year Performance42.13%116.48%35.40%14.61% Electromed Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)ELMDElectromed1.2693 of 5 stars$20.78+2.3%$38.00+82.9%+42.1%$174.26M$61.44M27.71160News CoverageCBLLCeriBell2.121 of 5 stars$18.73-0.9%$32.14+71.6%N/A$676.90M$65.44M0.00N/ABBNXBeta BionicsN/A$14.56-3.4%$23.44+61.0%N/A$631.32M$65.12M0.00294AVNSAvanos Medical2.509 of 5 stars$12.25+0.3%N/A-36.4%$566.44M$687.80M-1.462,227EMBCEmbecta4.289 of 5 stars$9.69+0.5%$19.33+99.5%-14.5%$566.28M$1.12B10.772,100BVSBioventus3.4318 of 5 stars$6.62-2.2%$14.33+116.5%+21.3%$543.79M$567.70M-10.851,200Positive NewsRXSTRxSight1.4207 of 5 stars$13.00+2.6%$37.90+191.5%-76.8%$528.32M$139.93M-19.40220News CoverageKIDSOrthoPediatrics4.2435 of 5 stars$21.48+0.5%$35.83+66.8%-25.0%$521.69M$212.45M-12.27200AXGNAxoGen2.7439 of 5 stars$10.85+3.3%$22.20+104.6%+42.6%$494.11M$187.34M-72.33450Positive NewsHigh Trading VolumeBFLYButterfly Network2.5221 of 5 stars$2.00+1.8%$4.00+100.5%+103.2%$493.34M$82.06M-6.88460News CoverageAnalyst ForecastGap DownDCTHDelcath Systems3.627 of 5 stars$13.60+0.2%$24.00+76.5%+60.9%$473.69M$37.21M-27.2060 Related Companies and Tools Related Companies CBLL Competitors BBNX Competitors AVNS Competitors EMBC Competitors BVS Competitors RXST Competitors KIDS Competitors AXGN Competitors BFLY Competitors DCTH Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NYSE:ELMD) was last updated on 7/4/2025 by MarketBeat.com Staff From Our PartnersElon’s NEXT Big IPO?Cancel your internet TODAY!? Take your latest internet bill and light it on fire… then count the seconds it...Banyan Hill Publishing | SponsoredPresidential Bombshell: $150T Resource to Be Released as soon as this Summer?Something extraordinary is happening in Washington. For the first time in over a century, a sitting Preside...Paradigm Press | SponsoredPost-Halving = Profit Season (Here’s How to Win It)It happens like clockwork. Every four years, the crypto market enters a new phase — and for those who know how...Crypto Swap Profits | SponsoredTop Picks for Trump’s Pro-Crypto AmericaMark August 12th on your calendar. 27 of crypto's most successful minds are about to reveal everything…Crypto 101 Media | SponsoredRevealed: NEW A.I. revolution (nobody is talking about)Nvidia's CEO says this is: "The next wave of A.I." We're at the cusp of a new "A.I. Upgrade" that is set to...Behind the Markets | SponsoredWhite House to reset Social Security?Elon Musk's parting DOGE gift looks set to shock America... A single announcement by July 22nd could soon b...Altimetry | SponsoredThe #1 AI Energy StockNearly $600 billion is projected to be spent on AI data centers this year. That's because the ones being bu...Weiss Ratings | SponsoredGold: Now legal tender in many statesThe perfect gold play right now? (currently under $10) Everything in the news now lines up perfectly for an...Stansberry Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Electromed, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Electromed With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
